Stifel Nicolaus analyst Simon Yarmak maintained a Buy rating on Camden Property (CPT – Research Report) yesterday and set a price target of $144.00. The company’s shares closed yesterday at $115.55.
Yarmak covers the Financial sector, focusing on stocks such as Agree Realty, National Retail Properties, and Hersha Hospitality. According to TipRanks, Yarmak has an average return of 10.9% and a 59.17% success rate on recommended stocks.
In addition to Stifel Nicolaus, Camden Property also received a Buy from RBC Capital’s Brad Heffern in a report issued yesterday. However, on October 27, BMO Capital maintained a Hold rating on Camden Property (NYSE: CPT).
See the top stocks recommended by analysts >>
The company has a one-year high of $176.74 and a one-year low of $109.66. Currently, Camden Property has an average volume of 858.6K.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CPT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Camden Property Trust operates as a real estate investment trust, which engages in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment communities. It focuses on maintaining a geographically portfolio of apartment homes located across the U.S. The company was founded by Richard J. Campo and D. Keith Oden on May 25, 1993 and is headquartered in Houston, TX.
Read More on CPT:
- Camden Property reports Q3 AFFO $1.47, consensus $1.70
- As Home Sales Plummet, These Apartment Stocks Could Make Money
- Camden Property estimates $1.0M in expenses related to Hurricane Ian
- Camden Property price target lowered to $152 from $175 at Stifel
- Camden Property price target lowered to $142 from $165 at Piper Sandler
